UiPath’s (PATH) Hold Rating Reiterated at TD Cowen

TD Cowen restated their hold rating on shares of UiPath (NYSE:PATH) in a report released on Wednesday,Benzinga reports. TD Cowen currently has a $16.00 price target on the stock.

PATH has been the topic of a number of other reports. UBS Group reduced their price objective on shares of UiPath from $19.00 to $15.00 and set a “neutral” rating on the stock in a research note on Wednesday. Barclays lifted their target price on shares of UiPath from $14.00 to $17.00 and gave the stock an “equal weight” rating in a research note on Friday, September 4th. Truist Financial boosted their target price on shares of UiPath from $12.00 to $17.00 and gave the company a “hold” rating in a report on Friday, September 4th. BMO Capital Markets boosted their target price on shares of UiPath from $13.00 to $18.00 and gave the company a “market perform” rating in a report on Friday, September 4th. Finally, Citigroup assumed coverage on shares of UiPath in a research report on Tuesday, September 8th. They set a “buy” rating and a $23.00 price target on the stock. Four analysts have rated the stock with a Buy rating, sixteen have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, UiPath has an average rating of “Hold” and a consensus price target of $16.06.

UiPath Price Performance

UiPath stock opened at $12.47 on Wednesday. The stock’s 50 day moving average is $14.53 and its 200 day moving average is $12.23. UiPath has a one year low of $9.20 and a one year high of $19.84. The firm has a market cap of $6.50 billion, a P/E ratio of 18.62, a P/E/G ratio of 1.18 and a beta of 1.02.

UiPath (NYSE:PATH) last released its earnings results on Thursday, September 3rd. The company reported $0.15 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.15. UiPath had a net margin of 21.03% and a return on equity of 9.70%. The business had revenue of $410.26 million during the quarter, compared to the consensus estimate of $397.77 million. During the same quarter in the prior year, the firm posted $0.15 EPS. The company’s revenue for the quarter was up 13.3% compared to the same quarter last year. Equities analysts anticipate that UiPath will post 0.49 earnings per share for the current fiscal year.

Insider Buying and Selling at UiPath

In other news, COO Ashim Gupta sold 117,339 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $13.85, for a total transaction of $1,625,145.15. Following the completion of the sale, the chief operating officer owned 2,037,377 shares of the company’s stock, valued at $28,217,671.45. This trade represents a 5.45% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Daniel Dines sold 1,402,347 shares of UiPath stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $16.07, for a total transaction of $22,535,716.29. Following the completion of the sale, the chief executive officer owned 26,491,238 shares of the company’s stock, valued at $425,714,194.66. This represents a 5.03% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 1,560,150 shares of company stock valued at $24,727,357. 22.44% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Pasadena Private Wealth LLC grew its position in UiPath by 9.0% in the 1st quarter. Pasadena Private Wealth LLC now owns 12,750 shares of the company’s stock valued at $142,000 after purchasing an additional 1,050 shares during the period. Allworth Financial LP increased its stake in UiPath by 5.2% during the 2nd quarter. Allworth Financial LP now owns 23,537 shares of the company’s stock valued at $256,000 after purchasing an additional 1,160 shares in the last quarter. EverSource Wealth Advisors LLC raised its holdings in UiPath by 36.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 4,968 shares of the company’s stock worth $81,000 after buying an additional 1,329 shares during the last quarter. Corient Private Wealth LLC raised its holdings in UiPath by 5.6% during the fourth quarter. Corient Private Wealth LLC now owns 27,283 shares of the company’s stock worth $447,000 after buying an additional 1,455 shares during the last quarter. Finally, Wedbush Securities Inc. lifted its stake in shares of UiPath by 14.0% in the second quarter. Wedbush Securities Inc. now owns 11,920 shares of the company’s stock valued at $130,000 after buying an additional 1,465 shares in the last quarter. 62.50% of the stock is owned by institutional investors.

UiPath News Summary

Here are the key news stories impacting UiPath this week:

• Positive Sentiment: UiPath customer adoption is demonstrating real-world demand for agentic automation, with one customer reportedly processing approximately 100,000 medical billing cases per week. This supports the company’s case that its technology can deliver measurable productivity gains at enterprise scale. Accountable intelligence – how a UiPath customer is using agentic automation to process 100,000 medical billing cases a week
• Positive Sentiment: The company introduced Cartographer and additional workflow automation and software-testing capabilities intended to connect business processes, software agents and enterprise AI orchestration. These tools could expand UiPath’s addressable market if they accelerate customer adoption. UiPath’s new tool could unlock a much bigger wave of automated business processes
• Positive Sentiment: UiPath announced the 2026 GeekWire AI Breakthrough Award winners, showcasing enterprises using agentic AI in production. The recognition may improve market visibility and reinforce the company’s positioning in enterprise AI. UiPath Announces Winners of the 2026 Geekwire AI Breakthrough Awards
• Neutral Sentiment: Needham reaffirmed its Buy rating, while Barclays and TD Cowen maintained Hold ratings, indicating mixed Wall Street conviction rather than a clear consensus. Needham reaffirms Buy rating
• Negative Sentiment: BMO Capital Markets cut its price target from $18 to $15 and Canaccord Genuity reduced its target from $17 to $14; both firms now carry middle-ground ratings. UBS also lowered its target, adding to investor concerns about UiPath’s near-term upside. Why UiPath stock is down today
• Negative Sentiment: The stock’s decline was compounded by rising Treasury yields and a broader software-sector selloff. Although annual recurring revenue reached $1.938 billion, investors appeared focused on valuation pressure and the shares’ persistent monthly downtrend. UiPath stock falls as ARR reaches $1.938 billion

UiPath Company Profile

UiPath Inc (NYSE: PATH) develops enterprise automation software designed to help organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation (RPA), artificial intelligence, workflow orchestration and process intelligence to support automation across areas such as finance, customer service, human resources, information technology and operations.

The UiPath Platform includes tools for discovering and analyzing business processes, building and managing software robots, processing documents, testing applications and coordinating automated workflows.